Chargement en cours...
Cued memory decline in biomarker-defined preclinical Alzheimer disease
OBJECTIVE: To determine whether a decline in cued recall is observable in the preclinical stage of Alzheimer disease (AD) in clinically normal older adults with elevated β-amyloid (Aβ) burden on PET imaging. METHODS: Clinically normal older adults underwent baseline neuroimaging (PET to assess Aβ(+/...
Enregistré dans:
| Publié dans: | Neurology |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams & Wilkins
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386436/ https://ncbi.nlm.nih.gov/pubmed/28283594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003812 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|